Literature DB >> 7631818

Reduction of thiazine dyes by bovine pulmonary arterial endothelial cells in culture.

R D Bongard1, M P Merker, R Shundo, Y Okamoto, D L Roerig, J H Linehan, C A Dawson.   

Abstract

The uptake of methylene blue (MB), and toluidine blue O (TBO) by bovine pulmonary arterial endothelial cells grown on microcarrier beads was detected as a decrease in the concentration of dye in the medium after these thiazine dyes were added to the medium surrounding the cells. Because the reduced forms of these dyes are much more lipophilic than the oxidized forms, we considered the possibility that reduction of the dyes at the cell surface might have preceded the uptake by the cells. Therefore, we studied the ability of the cells to reduce a toluidine blue O-polyacrylamide polymer (TBOP), which was too large to enter the cells in either the oxidized or reduced form. The TBO moieties of the polymer were reduced by the cells, indicating that the dyes did not have to enter the cells to be reduced and that reduction can occur at, or near, the cell surface. The rate of TBOP reduction was about the same as the rate of uptake of the monomeric dyes, indicating that the cell surface reduction mechanism had a sufficient capacity to account for the monomer uptake by the cells. We also found that ferricyanide ion, which also did not permeate the cells, was reduced by the cells and that external ferricyanide inhibited the monomeric MB uptake. Thus the results with ferricyanide were also consistent with the concept that the monomeric thiazine dyes are reduced at the cell surface before the more lipophilic reduced forms are taken up by the endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631818     DOI: 10.1152/ajplung.1995.269.1.L78

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Quantifying mitochondrial and plasma membrane potentials in intact pulmonary arterial endothelial cells based on extracellular disposition of rhodamine dyes.

Authors:  Zhuohui Gan; Said H Audi; Robert D Bongard; Kathryn M Gauthier; Marilyn P Merker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

2.  Toluidine blue for the intraoperative staining of the ureters. Studies on the safe administration in rats.

Authors:  Frank Petrat; Matthias Hartmann; Ernst Schmidt; Florian Grabellus; Tim Hamburger; Herbert de Groot
Journal:  Langenbecks Arch Surg       Date:  2012-08       Impact factor: 3.445

3.  Behavioral, Physiological and Biochemical Hormetic Responses to the Autoxidizable Dye Methylene Blue.

Authors:  Aleksandra K Bruchey; F Gonzalez-Lima
Journal:  Am J Pharmacol Toxicol       Date:  2008-01-01

4.  Distribution of capillary transit times in isolated lungs of oxygen-tolerant rats.

Authors:  Madhavi Ramakrishna; Zhuohui Gan; Anne V Clough; Robert C Molthen; David L Roerig; Said H Audi
Journal:  Ann Biomed Eng       Date:  2010-06-15       Impact factor: 3.934

5.  Methylene blue covalently loaded polyacrylamide nanoparticles for enhanced tumor-targeted photodynamic therapy.

Authors:  Ming Qin; Hoe Jin Hah; Gwangseong Kim; Guochao Nie; Yong-Eun Koo Lee; Raoul Kopelman
Journal:  Photochem Photobiol Sci       Date:  2011-04-09       Impact factor: 3.982

6.  Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity.

Authors:  Cliona Stack; Shari Jainuddin; Ceyhan Elipenahli; Meri Gerges; Natalia Starkova; Anatoly A Starkov; Mariona Jové; Manuel Portero-Otin; Nathalie Launay; Aurora Pujol; Navneet Ammal Kaidery; Bobby Thomas; Davide Tampellini; M Flint Beal; Magali Dumont
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

7.  Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness.

Authors:  Wei Tang; Hao Xu; Edwin J Park; Martin A Philbert; Raoul Kopelman
Journal:  Biochem Biophys Res Commun       Date:  2008-02-25       Impact factor: 3.575

8.  Coenzyme Q1 redox metabolism during passage through the rat pulmonary circulation and the effect of hyperoxia.

Authors:  Said H Audi; Marilyn P Merker; Gary S Krenz; Taniya Ahuja; David L Roerig; Robert D Bongard
Journal:  J Appl Physiol (1985)       Date:  2008-08-14

9.  Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance.

Authors:  Ayman Khdair; Di Chen; Yogesh Patil; Linan Ma; Q Ping Dou; Malathy P V Shekhar; Jayanth Panyam
Journal:  J Control Release       Date:  2009-09-11       Impact factor: 9.776

10.  Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.

Authors:  Robert D Bongard; Brian J Lindemer; Gary S Krenz; Marilyn P Merker
Journal:  Free Radic Biol Med       Date:  2008-09-20       Impact factor: 7.376

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.